A system of barcoding isotopically encoded particles in combination with elemental analyses and imaging that includes a particulate matrix, at least one isotope label contained in the particulate matrix, where the isotope label operates as i) an elemental identifier, ii) a mass identifier, or iii) an elemental identifier and a mass identifier, where the matrix operates as multi-digit particulate barcodes, at least i) a mass-based imager, ii) an elemental analyzer, iii) or the mass-based imager and the elemental analyzer, and a debarcoding algorithm and an automated machine learning analysis algorithm programmed on a computer to computational extract the multi-digit particulate barcodes for quantification of spatial nanotag distributions in ion beam imaging areas.

The present disclosure provides a system comprising a communication interface and computer for assigning a label to the biomolecule fingerprint, wherein the label corresponds to a biological state. The present disclosure also provides a sensor arrays for detecting biomolecules and methods of use. In some embodiments, the sensor arrays are capable of determining a disease state in a subject.

The present disclosure provides a system comprising a communication interface and computer for assigning a label to the biomolecule fingerprint, wherein the label corresponds to a biological state. The present disclosure also provides a sensor arrays for detecting biomolecules and methods of use. In some embodiments, the sensor arrays are capable of determining a disease state in a subject.

Two or more upconverting particles are attached to each unit of one or more units of a chemical component in a sample, to form, for each unit of the chemical component, a multi-particle complex including the unit of the chemical component and two or more corresponding upconverting particles. The sample is illuminated by input light having a first wavelength. Light is received at an imaging sensor, the received light including output light generated by at least a portion of the upconverting particles attached to the units of the chemical component, the output light having a second wavelength that is shorter than the first wavelength. One or more images of the sample are captured from the received light. Based on the captured one or more images, a presence or a level of the chemical component in the sample is determined.

Some embodiments relate to nanoparticle probes for the detection of disease states in a patient or for tissue engineering. In some embodiments, the nanoparticle probe comprises one or more slip bonds that bind to a cell surface structure. In some embodiments, the binding of the nanoparticle probe is selective. In some embodiments, the nanoparticle probe binds to cells having a certain maximum glycocalyx thickness.

Nanodiamond particles and related devices and methods, such as nanodiamond particles for the detection and/or quantification of analytes, are generally described. In some embodiments, the device comprises a plurality of nanodiamond particles and a species bound to the nanodiamond particles. In certain embodiments, the plurality of nanodiamond particles may be exposed to a sample suspected of containing an analyte. In some cases, the analyte may bind to the species such that the presence of the analyte in the sample may be detected. In some embodiments, the devices, systems, and methods described herein are useful for the detection of an analyte in a sample obtained from a subject for, for example, diagnostic purposes. In some cases, the systems, devices, and methods described herein may be useful for diagnosing, prevent, treating, and/or managing a disease or bodily condition. In an exemplary embodiment, such systems, devices, and methods described herein may be useful for detecting and/or quantifying the presence of a virus (e.g., ebola) in a subject and/or a sample obtained from the subject.

A method for forming dendritic mesoporous nanoparticles comprising preparing a mixture containing one or more polymer precursors, a silica precursor, and a compound that reacts with silica and reacts with the polymer or oligomer formed from the one or more polymer precursors, and stirring the mixture whereby nanoparticles are formed, and subsequently treating the nanoparticles to form dendritic mesoporous silica nanoparticles or dendritic mesoporous carbon nanoparticles. The silica precursor may comprise tetraethyl orthosilicate (TEOS), the one or more polymer precursors may comprise 3-aminophenol and formaldehyde and the compound may be ethylene diamine (EDA). There is a window of amount of EDA present that will result in asymmetric particles being formed. If a greater amount of EDA is present, symmetrical particles will be formed.

The present disclosure provides sensor arrays for detecting biomolecules and methods of use. In some embodiments, the sensor arrays are capable of determining a disease state in a subject.

The present invention relates to an in vitro method for detecting and/or quantifying a biological or chemical substance of interest in a liquid sample, by a capillary action test using, as probes, photoluminescent inorganic nanoparticles, of formula A.sub.1-xLn.sub.xVO.sub.4(1-y)(PO.sub.4).sub.y (II), in which Ln is selected from europium (Eu), dysprosium (Dy), samarium (Sm), neodymium (Nd), erbium (Er), ytterbium (Yb), thulium (Tm), praseodymium (Pr), holmium (Ho) and mixtures thereof; A is selected from yttrium (Y), gadolinium (Gd), lanthanum (La), lutetium (Lu), and mixtures thereof; 0<x<1; and 0≤y<1, said method employing detection of the luminescence, with an emission lifetime shorter than 100 ms, of the nanoparticles, after one-photon absorption, by excitation of the matrix at a wavelength less than or equal to 320 nm.

It also relates to a capillary action test device comprising, as probes, the aforementioned nanoparticles, as well as the use of such a method for purposes of in vitro diagnostics.

A preparation method and secondary dispersion of monodisperse aminated Nanodiamond colloid solution and its application in cellular biomarking are provided. Preparation method comprise: mixing purified Nanodiamond powder with ammonium chloride and sodium chloride, placing the mixture in a ball mill for dry ball milling, washing the ball-milled mixture with deionized water, and performing ultrasonic dispersion and centrifuging to obtain the monodispersed aminated Nanodiamond colloid solution. Secondary dispersion process comprising: drying aminated Nanodiamond colloid solution to obtain aminated Nanodiamond powder, re-dispersing the powder in DMSO (dimethyl sulphoxide), deionized water, ethanol, DMF (dimethylformamide) or other solvents with ultrasonic or shearing processing. The aminated Nanodiamond has high yield and good monodispersity. The preparation method is simple to operate, no special requirements on reaction equipment, no inert gas atmosphere is required in the whole reaction process and it is easy to be industrialized. The aminated Nanodiamond can be applied to cellular biomarking.